Thomas Collis

@alphavestcap There is now!! Thanks for the update 🥳

investorshub.advfn.com/boards/read_ms… $nwbo @alphavestcap Post# of 816864 Now, I expect the Final ECA Guidance publication (below) very very soon. gov.uk/government/con… flipper44 Just a reminder that early fall is when Dr. Ashkan thought a decision might be made on the MAA in a couple months, and 60 days after he said that, the CHM, imo, advised on DCVax-lRare Cancers Act Stage…………………….. Date Commons 1st Reading 16 Oct 2024 Commons 2nd Reading 14 Mar 2025 Commons Committee 2 Jul 2025 Commons Report 11 Jul 2025 Commons 3rd Reading 11 Jul 2025 Lords 1st Reading 14 Jul 2025* Lords 2nd Reading 16 Jan 2026** Lords Committee 11 Feb 2026 Lords 3rd Reading 27 Feb 2026 (Effectively Adopted) Royal Assent 5 March 2026 (Formally Adopted) Note: * July 14 2025: also, ECA draft guidance closed consult and went into editing. ** January 15th (16th GMT) 2026: also, LP filed Delaware settlement so it can be signed 60 days later on March 16 2026. Note: Linda Powers, December 29, 2025”Noteworthy, we think, is that while we’ve been going through this very, very, very long process, there have been a number of really important developments taking place in the field, moving in our direction. You’ve probably seen these. For example, in May of this year (2025), the MHRA issued a draft guidance document that would give permission for clinical trials to start using external controls, and MHRA received public comment all through the summer. Our understanding is it received lots of comments, very positive. And our understanding is that in the early fall (2025), the MHRA announced that it now plans to make that formal and definite. That’s huge. That’s amazing, given how much controversy there had been over that subject.”

@alphavestcap There is no record of Royal Assent on March 5

$NWBO Rare Cancers Bill passed 2/27/26...now set to become Law !!!

@d_stock07734 God bless you 🙏

$NWBO youtu.be/-gFnLZBcN38?si… youtu.be/T_7JN2Ks-nc?si… Dendritic Cell Vaccines Changing Landscape for Breast Cancer Treatment moffitt.org/endeavor/archi…

@jascanlan That confirms what I had stated that the CDR was run on 1/10/26. Since that trade on 1/23/26 was "OFF BOOK" the timing of public disclosure is.... Only time will tell for sure

@BioZip8 Data will be injected throughout the test to generate market data to assist with testing of the new TRADEcho GTP market data channels and instrument rebalancing across channels…….. SI Quotes sent during the dress rehearsal will be considered test quotes.

$NWBO XLOM OFF-BOOK REPORTING VOLUME: 1,564,220 SHARES PRICE: $1.51 USD (€1.31) VENUE: XLOM (LSE OFF-BOOK MTF) DATE/TIME: FRI JAN 23, 2026 (LATE SESSION) Bullish Jan 25, 2026 8:42 PM

@jascanlan There was no announcement indicating fictitious data would be in production 1/23-1/26. A CDR was run on Saturday 1/10/26. If you have a Service Announcement you are referring to, please share.

@BioZip8 This was likely test data as the LSE switches notification platforms. Their service announcements suggested fictitious data would be in productions feeds jan 23-26 during market close hours. Unfortunately, I think we ignore this one for $NWBO

$NWBO

$NWBO Rare Cancers Bill Passes Second reading...next step sign it into Law !! theedinburghreporter.co.uk/2026/01/rare-c…

$GLYC sciencedirect.com/science/articl…

$GLYC bnnbreaking.com/world/us/glyco…

Happy to present at the @VenousForum #VENOUS2023 the results of the first human study on E-Selectin inhibitor #Uproleselan for #COVID19 this Friday! #GlycoMimetics

$NWBO #CitadelScandal $APE $GME Slap the ask...ALL DAY...EVERY DAY !!! #JUSTICEFORCANCERPATIENTS

@FlemmingBruce cassavasciences.com/news-releases/…

$NWBO Those who are unaware. NWBO and AdventBio is situated in the same building in Sawston, Cambridge. AdventBio do NWBO's bidding regarding production of DCVax-L. CEO Linda Powers in NWBO, OWNS AdventBio. Only a small sub-lease of the area is for other clients. -->

@sentimentstock @statnews cassavasciences.com/news-releases/…

When it comes to @statnews' investigative abilities regarding $NWBO, you've performed terribly, citing endpoints that had been changed for a year and a half in your 5/10/22 hit piece. What makes it even worse is that you knew the endpoints had been changed. That's NOT journalism!

@apwriter cassavasciences.com/news-releases/…

@drgauravchandra swfinstitute.org/news/91103/in-…

@biggercapital @CreechTurner @adamfeuerstein BCRX should be added to that list, grossly undervalued due to the short attack. 37 million shorts should burn

@CreechTurner @adamfeuerstein I have no idea but @adamfeuerstein has been so wrong on what the intelligencia calls bioturds over the past 8 months. They've been a gold mine.

What say you @adamfeuerstein ? $NWBO Next? $CVM $GME

$ATNM early but very promising. Actinium225 phase 1 #astella @BayerUS $NVS $BMY $MRK $PFE $AMGN $ABBV $VRTX